Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'classical complement pathway' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 62 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Bos, IGAC; van Mierlo, GJ; Bleeker, WK; Rigter, GMM; Velthuis, HT; Dickneite, G; Hack, CE
      The potentiation of human C1-inhibitor by dextran sulphate is transient invivo: studies in a rat model

      INTERNATIONAL IMMUNOPHARMACOLOGY
    2. Tooyama, I; Sato, H; Yasuhara, O; Kimura, H; Konishi, Y; Shen, Y; Walker, DG; Beach, TG; Sue, LI; Rogers, J
      Correlation of the expression level of C1q mRNA and the number of C1q-positive plaques in the Alzheimer disease temporal cortex analysis of C1q mRNA and its protein using adjacent or nearby sections

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    3. Hoozemans, JJM; Rozemuller, AJM; Veerhuis, R; Eikelenboom, P
      Immunological aspects of Alzheimer's disease - Therapeutic implications

      BIODRUGS
    4. Fonseca, MI; Carpenter, PM; Park, M; Palmarini, G; Nelson, EL; Tenner, AJ
      C1qR(p), a myeloid cell receptor in blood, is predominantly expressed on endothelial cells in human tissue

      JOURNAL OF LEUKOCYTE BIOLOGY
    5. Klegeris, A; Schwab, C; Bissonnette, CJ; McGeer, PL
      Induction of complement C9 messenger RNAs in human neuronal cells by inflammatory stimuli: relevance to neurodegenerative disorders

      EXPERIMENTAL GERONTOLOGY
    6. Navratil, JS; Watkins, SC; Wisnieski, JJ; Ahearn, JM
      The globular heads of C1q specifically recognize surface blebs of apoptotic vascular endothelial cells

      JOURNAL OF IMMUNOLOGY
    7. Hull, M; Lieb, K; Fiebich, BL
      Anti-inflammatory drugs: a hope for Alzheimer's disease?

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    8. Iseki, E; Marui, W; Akiyama, H; Ueda, K; Kosaka, K
      Degeneration process of Lewy bodies in the brains of patients with dementia with Lewy bodies using alpha-synuclein-immunohistochemistry

      NEUROSCIENCE LETTERS
    9. Vickers, JC; Dickson, TC; Adlard, PA; Saunders, HL; King, CE; McCormack, G
      The cause of neuronal degeneration in Alzheimer's disease

      PROGRESS IN NEUROBIOLOGY
    10. Kelsoe, G
      Studies of the humoral immune response

      IMMUNOLOGIC RESEARCH
    11. Akiyama, H; Barger, S; Barnum, S; Bradt, B; Bauer, J; Cole, GM; Cooper, NR; Eikelenboom, P; Emmerling, M; Fiebich, BL; Finch, CE; Frautschy, S; Griffin, WST; Hampel, H; Hull, M; Landreth, G; Lue, LF; Mrak, R; Mackenzie, IR; McGeer, PL; O'Banion, MK; Pachter, J; Pasinetti, G; Plata-Salaman, C; Rogers, J; Rydel, R; Shen, Y; Streit, W; Strohmeyer, R; Tooyoma, I; Van Muiswinkel, FL; Veerhuis, R; Walker, D; Webster, S; Wegrzyniak, B; Wenk, G; Wyss-Coray, T
      Inflammation and Alzheimer's disease

      NEUROBIOLOGY OF AGING
    12. Straatsburg, IH; Boermeester, MA; Wolbink, GJ; van Gulik, TM; Gouma, DJ; Frederiks, WM; Hack, CE
      Complement activation induced by ischemia-reperfusion in humans: a study in patients undergoing partial hepatectomy

      JOURNAL OF HEPATOLOGY
    13. Caliezi, C; Wuillemin, WA; Zeerleder, S; Redondo, M; Eisele, B; Hack, CE
      C1-esterase inhibitor: An anti-inflammatory agent and its potential use inthe treatment of diseases other than hereditary angioedema

      PHARMACOLOGICAL REVIEWS
    14. Van Molle, W; Hochepied, T; Brouckaert, P; Libert, C
      The major acute-phase protein, serum amyloid P component, in mice is not involved in endogenous resistance against tumor necrosis factor alpha-induced lethal hepatitis, shock, and skin necrosis

      INFECTION AND IMMUNITY
    15. Nogueras, MM; Merino, S; Aguilar, A; Benedi, VJ; Tomas, JM
      Cloning, sequencing, and role in serum susceptibility of porin II from mesophilic Aeromonas hydrophila

      INFECTION AND IMMUNITY
    16. Klegeris, A; Bissonnette, CJ; Dorovini-Zis, K; McGeer, PL
      Expression of complement messenger RNAs by human endothelial cells

      BRAIN RESEARCH
    17. McGeer, EG; McGeer, PL
      Brain inflammation in Alzheimer disease and the therapeutic implications

      CURRENT PHARMACEUTICAL DESIGN
    18. Hull, M; Fiebich, BL; Schumann, G; Lieb, K; Bauer, J
      Anti-inflammatory substances a new therapeutic option in Alzheimer's disease

      DRUG DISCOVERY TODAY
    19. Paul, E; Carroll, MC
      SAP-less chromatin triggers systemic lupus erythematosus

      NATURE MEDICINE
    20. McGeer, PL; McGeer, EG
      Inflammation of the brain in Alzheimer's disease: implications for therapy

      JOURNAL OF LEUKOCYTE BIOLOGY
    21. Wing, MG; Seilly, DJ; Nicholas, RS; Rahman, S; Zajicek, J; Lachmann, PJ; Compston, DAS
      Comparison of C1q-receptors on rat microglia and peritoneal macrophages

      JOURNAL OF NEUROIMMUNOLOGY
    22. Lund, V; Olafsen, JA
      Changes in serum concentration of a serum amyloid P-like pentraxin in Atlantic salmon, Salmo salar L., during infection and inflammation

      DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY
    23. Lawrie, CH; Randolph, SE; Nuttall, PA
      Ixodes ticks: Serum species sensitivity of anticomplement activity

      EXPERIMENTAL PARASITOLOGY
    24. Hochgrebe, TT; Humphreys, D; Wilson, MR; Easterbrook-Smith, SB
      A reexamination of the role of clusterin as a complement regulator

      EXPERIMENTAL CELL RESEARCH
    25. Siegert, CEH; Kazatchkine, MD; Sjoholm, A; Wurzner, R; Loos, M; Daha, MR
      Autoantibodies against C1q: view on clinical relevance and pathogenic roles

      CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    26. Bradley, AJ; Brooks, DE; Norris-Jones, R; Devine, DV
      Clq binding to liposomes is surface charge dependent and is inhibited by peptides consisting of residues 14-26 of the human ClqA chain in a sequence independent manner

      BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
    27. ISHIDA T; IIDA S; FUNATO K; KIWADA H
      A NOVEL PLASMA FACTOR INITIATING COMPLEMENT ACTIVATION ON CETYLMANNOSIDE-MODIFIED LIPOSOMES IN HUMAN PLASMA

      International journal of pharmaceutics
    28. KOPPENHEFFER TL; SPONG KD; FALVO HM
      THE COMPLEMENT-SYSTEM OF THE MARSUPIAL MONODELPHIS-DOMESTICA

      Developmental and comparative immunology
    29. KOJOUHAROVA MS; PANCHEV ID; TCHORBADJIEVA MI; REID KBM; HOPPE HJ
      DIFFERENTIAL BINDING OF IGG AND OF A HIV GP41 PEPTIDE BY THE B-CHAIN AND A-CHAIN GLOBULAR HEAD SEQUENCES OF C1Q, RESPECTIVELY

      The Journal of immunology (1950)
    30. DEHAAS CJC; VANDERTOL ME; VANKESSEL KPM; VERHOEF J; VANSTRIJP JAG
      A SYNTHETIC LIPOPOLYSACCHARIDE-BINDING PEPTIDE-BASED ON AMINO-ACIDS 27-39 OF SERUM AMYLOID-P COMPONENT INHIBITS LIPOPOLYSACCHARIDE-INDUCED RESPONSES IN HUMAN BLOOD

      The Journal of immunology (1950)
    31. VANDENBERG RH; SIEGERT CEH; FABERKROL MC; HUIZINGA TWJ; VANES LA; DAHA MR
      ANTI-C1Q RECEPTOR CALRETICULIN AUTOANTIBODIES IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)/

      Clinical and experimental immunology
    32. SOURY E; OLIVIER E; DAVEAU M; HIRON M; CLAEYSSENS S; RISLER JL; SALIER JP
      THE H4P HEAVY-CHAIN OF INTER-ALPHA-INHIBITOR FAMILY LARGELY DIFFERS IN THE STRUCTURE AND SYNTHESIS OF ITS PROLINE-RICH REGION FROM RAT TO HUMAN

      Biochemical and biophysical research communications
    33. LAUVRAK V; BREKKE OH; IHLE O; LINDQVIST BH
      IDENTIFICATION AND CHARACTERIZATION OF C1Q-BINDING PHAGE DISPLAYED PEPTIDES

      Biological chemistry
    34. PEPYS MB; BOOTH DR; HUTCHINSON WL; GALLIMORE JR; COLLINS PM; HOHENESTER E
      AMYLOID-P COMPONENT - A CRITICAL-REVIEW

      AMYLOID-INTERNATIONAL JOURNAL OF EXPERIMENTAL AND CLINICAL INVESTIGATION
    35. KOJIMA T; DALCARPIO CA; HAYASHI S; YOKOYAMA I; TAKAGI H
      INHIBITION OF COMPLEMENT-MEDIATED IMMUNE HEMOLYSIS BY THE CONSTANT DOMAIN OF IMMUNOGLOBULIN

      Xenotransplantation
    36. DEVINE DV; MARJAN JMJ
      THE ROLE OF IMMUNOPROTEINS IN THE SURVIVAL OF LIPOSOMES IN THE CIRCULATION

      Critical reviews in therapeutic drug carrier systems
    37. AKATSU H; YAMADA T; OKADA N; YAMAMOTO T; YAMASHINA M; OKADA H
      UNIQUE EXPRESSION OF HRF20 (CD59) IN HUMAN NERVOUS-TISSUE

      Microbiology and immunology
    38. HANDA G; KAPIL A; SHARMA S; SINGH J
      LAWNERMIS ACID - A NEW ANTICOMPLEMENTARY TRITERPENOID FROM LAWSONIA-INERMIS SEEDS

      Indian journal of chemistry. Sect. B: organic chemistry, including medical chemistry
    39. HACK CE; WOLBINK GJ; SCHALKWIJK C; SPEIJER H; HERMENS WT; VANDENBOSCH H
      A ROLE FOR SECRETORY PHOSPHOLIPASE A(2) AND C-REACTIVE PROTEIN IN THEREMOVAL OF INJURED CELLS

      Immunology today
    40. SAFAYHI H; SAILER ER
      ANTIINFLAMMATORY ACTIONS OF PENTACYCLIC TRITERPENES

      Planta medica
    41. JENSEN LE; HINEY MP; SHIELDS DC; UHLAR CM; LINDSAY AJ; WHITEHEAD AS
      ACUTE-PHASE PROTEINS IN SALMONIDS - EVOLUTIONARY ANALYSES AND ACUTE-PHASE RESPONSE

      The Journal of immunology
    42. VAITH P; PRASAUSKAS V; POTEMPA LA; PETER HH
      COMPLEMENT ACTIVATION BY C-REACTIVE PROTEIN ON THE HEP-2 CELL SUBSTRATE

      International archives of allergy and immunology
    43. KNAUS U; WAGNER H
      EFFECTS OF BOSWELLIC-ACID OF BOSWELLIA-SERRATA AND OTHER TRITERPENIC ACIDS ON THE COMPLEMENT-SYSTEM

      Phytomedicine
    44. NI Y; TIZARD I
      LECTIN-CARBOHYDRATE INTERACTION IN THE IMMUNE-SYSTEM

      Veterinary immunology and immunopathology
    45. LUCAS SD; KARLSSONPARRA A; NILSSON B; GRIMELIUS L; AKERSTROM G; RASTAD J; JUHLIN C
      TUMOR-SPECIFIC DEPOSITION OF IMMUNOGLOBULIN-G AND COMPLEMENT IN PAPILLARY THYROID-CARCINOMA

      Human pathology
    46. LI XA; HATANAKA K; ISHIBASHIUEDA H; YUTANI C; YAMAMOTO A
      CHARACTERIZATION OF SERUM AMYLOID-P COMPONENT FROM HUMAN AORTIC ATHEROSCLEROTIC LESIONS

      Arteriosclerosis, thrombosis, and vascular biology
    47. GEWURZ H; ZHANG XH; LINT TF
      STRUCTURE AND FUNCTION OF THE PENTRAXINS

      Current opinion in immunology
    48. SCHLIMGEN AK; HELMS JA; VOGEL H; PERIN MS
      NEURONAL PENTRAXIN, A SECRETED PROTEIN WITH HOMOLOGY TO ACUTE-PHASE PROTEINS OF THE IMMUNE-SYSTEM

      Neuron
    49. HSU YC; PERIN MS
      HUMAN NEURONAL PENTRAXIN-II (NPTX2) - CONSERVATION, GENOMIC STRUCTURE, AND CHROMOSOMAL LOCALIZATION

      Genomics
    50. HARDIG Y; DEFRUTOS PG; DAHLBACK B
      EXPRESSION AND CHARACTERIZATION OF A RECOMBINANT C4B-BINDING PROTEIN LACKING THE BETA-CHAIN

      Biochemical journal
    51. ROGERS J
      INFLAMMATION AS A PATHOGENIC MECHANISM IN ALZHEIMERS-DISEASE

      Arzneimittel-Forschung
    52. SMYTH MD; CRIBBS DH; TENNER AJ; DICK M; KESSLAK JP; COTMAN CW; SHANKLE WR
      DECREASED LEVELS OF C1Q IN CEREBROSPINAL-FLUID OF LIVING ALZHEIMER PATIENTS CORRELATE WITH DISEASE STATE

      Neurobiology of aging
    53. GULATI P; GUC D; LEMERCIER C; LAPPIN D; WHALEY K
      EXPRESSION OF THE COMPONENTS AND REGULATORY PROTEINS OF THE CLASSICALPATHWAY OF COMPLEMENT IN NORMAL AND DISEASED SYNOVIUM

      Rheumatology international
    54. WISNIESKI JJ; KNAUSS TC; YIKE I; DEARBORN DG; NARVY RL; NAFF GB
      UNIQUE C1 INHIBITOR DYSFUNCTION IN A KINDRED WITHOUT ANGIOEDEMA .1. AMUTANT C1 INH THAT INHIBITS C(1)OVER-BAR-S BUT NOT C(1)OVER-BAR-R

      The Journal of immunology
    55. LANDSMANN P; ROSEN O; PONTET M; PRAS M; LEVARTOWSKY D; SHEPHARD EG; FRIDKIN M
      BINDING OF HUMAN SERUM AMYLOID-P COMPONENT (HSAP) TO HUMAN NEUTROPHILS

      European journal of biochemistry
    56. PEPYS MB; BOOTH SE; TENNENT GA; BUTLER PJG; WILLIAMS DG
      BINDING OF PENTRAXINS TO DIFFERENT NUCLEAR-STRUCTURES - C-REACTIVE PROTEIN BINDS TO SMALL NUCLEAR RIBONUCLEOPROTEIN-PARTICLES, SERUM AMYLOID-P COMPONENT BINDS TO CHROMATIN AND NUCLEOLI

      Clinical and experimental immunology
    57. SHOEMAKER LR; SCHURMAN SJ; DONALDSON VH; DAVIS AE
      HEREDITARY ANGIONEUROTIC-EDEMA - CHARACTERIZATION OF PLASMA KININ ANDVASCULAR PERMEABILITY-ENHANCING ACTIVITIES

      Clinical and experimental immunology
    58. CHRISTNER RB; MORTENSEN RF
      BINDING OF HUMAN SERUM AMYLOID P-COMPONENT TO PHOSPHOCHOLINE

      Archives of biochemistry and biophysics
    59. CHRISTNER RB; MORTENSEN RF
      BINDING OF HUMAN SERUM AMYLOID P-COMPONENT TO PHOSPHOCHOLINE

      Archives of biochemistry and biophysics
    60. KALARIA RN
      THE IMMUNOPATHOLOGY OF ALZHEIMERS-DISEASE AND SOME RELATED DISORDERS

      Brain pathology
    61. LYNCH DM; ASHMAN RB; KAY PH; PAPADIMITRIOU JM
      GENETIC, STRUCTURAL, AND FUNCTIONAL-STUDIES OF A C3-LIKE PROTEIN IN THE MARSUPIAL SETONIX-BRACHYURUS

      Experimental and clinical immunogenetics
    62. UEDA K; NAKAJIMA H; NAKAGAWA T; SHIMIZU A
      THE ASSOCIATION BETWEEN HEPATITIS-C VIRUS-INFECTION AND IN-VITRO ACTIVATION OF THE COMPLEMENT-SYSTEM

      Annals of clinical biochemistry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/05/20 alle ore 21:14:17